The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
A 15-mg dose with a corticosteroid taper regimen was superior to placebo in sustained remission from week 12 to 52.
Kalydeco Now Approved for Expanded Cystic Fibrosis Treatment
May 18th 2017FDA officials have announced the expanded approval of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to triple the number of rare gene mutations of cystic fibrosis that the drug is indicated to treat, from 10 mutations to 33.
Read More
Urine Test Identifies Zika Virus Fast, Could Prevent Birth Defects
May 16th 2017The results of a recent study from Beaumont Hospital in Royal Oak, Michigan, show that Zika virus can be identified by a urine test that does not require administration by a doctor and that delivers results in less than 30 minutes.
Read More